» Articles » PMID: 39578435

Artificial Intelligence to Diagnose Complications of Diabetes

Overview
Specialty Endocrinology
Date 2024 Nov 23
PMID 39578435
Authors
Affiliations
Soon will be listed here.
Abstract

Artificial intelligence (AI) is increasingly being used to diagnose complications of diabetes. Artificial intelligence is technology that enables computers and machines to simulate human intelligence and solve complicated problems. In this article, we address current and likely future applications for AI to be applied to diabetes and its complications, including pharmacoadherence to therapy, diagnosis of hypoglycemia, diabetic eye disease, diabetic kidney diseases, diabetic neuropathy, diabetic foot ulcers, and heart failure in diabetes.Artificial intelligence is advantageous because it can handle large and complex datasets from a variety of sources. With each additional type of data incorporated into a clinical picture of a patient, the calculation becomes increasingly complex and specific. Artificial intelligence is the foundation of emerging medical technologies; it will power the future of diagnosing diabetes complications.

References
1.
Maritsch M, Foll S, Lehmann V, Styger N, Berube C, Kraus M . Smartwatches for non-invasive hypoglycaemia detection during cognitive and psychomotor stress. Diabetes Obes Metab. 2023; 26(3):1133-1136. DOI: 10.1111/dom.15402. View

2.
Jensen M, Dethlefsen C, Vestergaard P, Hejlesen O . Prediction of Nocturnal Hypoglycemia From Continuous Glucose Monitoring Data in People With Type 1 Diabetes: A Proof-of-Concept Study. J Diabetes Sci Technol. 2019; 14(2):250-256. PMC: 7196854. DOI: 10.1177/1932296819868727. View

3.
Zhao D, Wang W, Tang T, Zhang Y, Yu C . Current progress in artificial intelligence-assisted medical image analysis for chronic kidney disease: A literature review. Comput Struct Biotechnol J. 2023; 21:3315-3326. PMC: 10275698. DOI: 10.1016/j.csbj.2023.05.029. View

4.
Morrow E, Zidaru T, Ross F, Mason C, Patel K, Ream M . Artificial intelligence technologies and compassion in healthcare: A systematic scoping review. Front Psychol. 2023; 13:971044. PMC: 9887144. DOI: 10.3389/fpsyg.2022.971044. View

5.
Ma S, Schreiner P, Seaquist E, Ugurbil M, Zmora R, Chow L . Multiple predictively equivalent risk models for handling missing data at time of prediction: With an application in severe hypoglycemia risk prediction for type 2 diabetes. J Biomed Inform. 2020; 103:103379. PMC: 7088462. DOI: 10.1016/j.jbi.2020.103379. View